Glaukos Corporation is dedicated to advancing ophthalmic care through the development of innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive glaucoma surgery (MIGS) devices and pharmaceuticals, aiming to improve patient outcomes and treatment options globally.
The Sr. Scientist II – Toxicology is responsible for providing subject matter expertise and leading toxicology and nonclinical development for ophthalmic therapeutics and devices. This role involves designing in vivo toxicology studies, evaluating data, overseeing study schedules, and ensuring regulatory compliance. The individual will contribute to the development plan and be a Key Contact for outsourced studies.
Glaukos Corporation is dedicated to advancing ophthalmic care through the development of innovative therapies for glaucoma, corneal disorders, and retinal diseases. The company specializes in minimally invasive glaucoma surgery (MIGS) devices and pharmaceuticals, aiming to improve patient outcomes and treatment options globally.